RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie, ...

Once considered cellular junk, non-coding RNAs are emerging as key players in everything from brain development to cancer — ...

How does the cell convert DNA into working proteins? The process of translation can be seen as the decoding of instructions for making proteins, involving mRNA in transcription as well as tRNA. But ...

In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

A data engineer from Sydney used AI to design what may be the world's first personalized mRNA cancer vaccine for a dog.